Overview
HealthEquity, Inc., based in the United States, operates predominantly within the health care sector, specifically focusing on technology-driven services that facilitate health savings accounts (HSAs) and other health financial services. Since its inception, the company has expanded its offerings to include reimbursement accounts such as FSAs, HRAs, as well as VEBA, and commuter benefits. A key project for HealthEquity involves integrating technology to simplify the management and accessibility of health accounts for both employers and account holders, emphasizing user-friendly platforms and 24/7 customer service. The company has also been actively working on partnerships and acquisitions to broaden its service capabilities and market reach, thereby consolidating its position as a leader in health account solutions in the U.S.
AI+ Ask Fintel’s AI assistant about HealthEquity, Inc..
Thinking about good questions…
Basic Stats
The share price of HealthEquity, Inc. as of September 10, 2025 is $91.51 / share. This is a decrease of -4.22% from the prior week. The market cap (or net worth) of HealthEquity, Inc. as of September 10, 2025 is $7,905.79 MM.
The Factor Analysis chart (below right) shows a view of HealthEquity, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 7,905.79 MM |
| EV | 8,608.17 MM |
| Shares Out. | 86.42 MM |
| Earnings Date | |
| EPS (TTM) | 1.69 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.25 |
| Short Shares Avail. | 1.70 MM |
| Short Interest | 5.01 MM |
| Short Float | 5.93 % |
| Days to Cover | 4.34 days |
| Risk Free Rate | 4.08 % |
| Price Change (1 yr) | 22.48 % |
| Volatility (1 yr) | 0.41 |
| Beta | 0.98 |
| Sharpe Ratio (1 yr) | 0.45 |
| Sortino Ratio (1 yr) | 0.70 |
| PE Ratio | 54.21 |
| Price/Book | 3.68 |
| Price/TBV | -12.09 |
| Book/Market | 0.27 |
| EBIT/EV | 0.02 |
| EBIT(3yr avg)/EV | 0.01 |
| ROA | 0.04 |
| ROE | 0.07 |
| ROIC | 0.05 |
| CROIC | -0.01 |
| OCROIC | 0.11 |
| Implied Volatility | 33.48 % |
| Put/Call OI Ratio | 0.31 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for HealthEquity, Inc. is $123.66. The forecasts range from a low of $105.04 to a high of $136.50. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for HealthEquity, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-24 | Deutsche Bank | Buy | Maintains | |
| 2023-02-03 | Wells Fargo | Overweight | Maintains | |
| 2022-12-12 | Raymond James | Outperform | Maintains | |
| 2022-12-07 | Wells Fargo | Overweight | Maintains | |
| 2022-12-07 | Guggenheim | Buy | Maintains | |
| 2022-12-05 | RBC Capital | Outperform | Maintains | |
| 2022-10-25 | Wells Fargo | Overweight | Maintains | |
| 2022-10-21 | Goldman Sachs | Sell | Neutral | Upgrade |
| 2022-09-16 | Keybanc | Overweight | Initiate | |
| 2022-09-13 | Wells Fargo | Overweight | Maintains | |
| 2022-09-12 | Raymond James | Outperform | Maintains | |
| 2022-09-08 | Deutsche Bank | Buy | Maintains | |
| 2022-09-07 | Baird | Neutral | Maintains | |
| 2022-07-12 | Goldman Sachs | Sell | Initiate | |
| 2022-06-08 | Deutsche Bank | Buy | Maintains | |
| 2022-06-07 | SVB Leerink | Outperform | Maintains | |
| 2022-04-11 | Wells Fargo | Overweight | Initiate | |
| 2022-04-07 | Guggenheim | Buy | Initiate | |
| 2022-03-30 | BTIG | Neutral | Buy | Upgrade |
| 2022-03-28 | Jefferies | Buy | Maintains | |
| 2022-03-24 | Deutsche Bank | Buy | Maintains | |
| 2022-02-24 | Deutsche Bank | Buy | Maintains | |
| 2021-12-21 | JP Morgan | Overweight | Maintains | |
| 2021-12-08 | Deutsche Bank | Buy | Maintains | |
| 2021-12-07 | RBC Capital | Outperform | Maintains | |
| 2021-12-07 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2021-12-02 | Jefferies | Buy | Initiate | |
| 2021-09-21 | Deutsche Bank | Buy | Maintains | |
| 2021-09-09 | SVB Leerink | Market Perform | Outperform | Upgrade |
| 2021-07-02 | Stephens & Co. | Overweight | Initiate | |
| 2021-06-10 | Raymond James | Strong Buy | Maintains | |
| 2021-06-08 | Cantor Fitzgerald | Overweight | Maintains | |
| 2021-03-22 | Raymond James | Strong Buy | Maintains | |
| 2021-03-17 | Deutsche Bank | Buy | Maintains | |
| 2021-03-16 | SVB Leerink | Market Perform | Maintains | |
| 2021-02-10 | Raymond James | Strong Buy | Maintains | |
| 2021-02-09 | RBC Capital | Outperform | Maintains | |
| 2021-01-07 | BTIG | Neutral | Initiate | |
| 2020-12-02 | SVB Leerink | Market Perform | Maintains | |
| 2020-12-02 | KeyBanc | Overweight | Sector Weight | Downgrade |
| 2020-11-23 | Guggenheim | Buy | Neutral | Downgrade |
| 2020-10-23 | RBC Capital | Outperform | Initiate | |
| 2020-09-09 | Wells Fargo | Overweight | Maintains | |
| 2020-09-09 | SVB Leerink | Market Perform | Maintains | |
| 2020-06-03 | Cantor Fitzgerald | Overweight | Maintains | |
| 2020-04-14 | Guggenheim | Buy | Initiate | |
| 2020-04-08 | Raymond James | Strong Buy | Reiterate | |
| 2020-03-27 | Raymond James | Strong Buy | Maintains | |
| 2020-03-26 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-03-18 | Deutsche Bank | Buy | Maintains | |
| 2020-03-17 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-03-17 | KeyBanc | Overweight | Maintains | |
| 2020-03-17 | Cantor Fitzgerald | Overweight | Reiterate | |
| 2020-03-17 | Baird | Neutral | Maintains | |
| 2020-02-20 | Deutsche Bank | Buy | Maintains | |
| 2020-02-19 | Wells Fargo | Overweight | Maintains | |
| 2020-02-19 | KeyBanc | Overweight | Maintains | |
| 2020-01-08 | Wells Fargo | Overweight | Maintains | |
| 2019-12-04 | KeyBanc | Overweight | Maintains | |
| 2019-10-07 | Goldman Sachs | Neutral | Initiate | |
| 2019-09-17 | KeyBanc | Overweight | Maintains | |
| 2019-09-12 | Deutsche Bank | Buy | Initiate | |
| 2019-09-09 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2019-09-04 | Wells Fargo | Outperformer | Maintains | |
| 2019-09-04 | Oppenheimer | Outperform | Maintains | |
| 2019-07-19 | Bank of America | Neutral | Buy | Upgrade |
| 2019-06-10 | Raymond James | Outperform | Reiterate | |
| 2019-03-19 | KeyBanc | Overweight | Overweight | Maintains |
| 2019-03-19 | Bank of America | Neutral | Neutral | Maintains |
| 2019-02-07 | SunTrust Robinson Humphrey | Hold | Buy | Upgrade |
| 2018-12-18 | Cantor Fitzgerald | Neutral | Overweight | Upgrade |
| 2018-12-07 | Wells Fargo | Outperform | Outperform | Maintains |
| 2018-12-06 | SunTrust Robinson Humphrey | Buy | Hold | Downgrade |
| 2018-12-06 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
| 2018-09-10 | Raymond James | Outperform | Outperform | Maintains |
| 2018-09-06 | Bank of America | Buy | Neutral | Downgrade |
| 2018-09-05 | Wells Fargo | Outperform | Outperform | Maintains |
| 2018-09-05 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
| 2018-09-04 | KeyBanc | Overweight | Overweight | Maintains |
| 2018-06-05 | KeyBanc | Overweight | Overweight | Maintains |
| 2018-06-05 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
| 2018-06-05 | Baird | Neutral | Neutral | Maintains |
| 2018-05-31 | Cantor Fitzgerald | Overweight | Neutral | Downgrade |
| 2018-04-24 | JP Morgan | Overweight | Overweight | Maintains |
| 2018-04-05 | KeyBanc | Overweight | Overweight | Maintains |
| 2018-03-20 | Oppenheimer | Outperform | Outperform | Maintains |
| 2018-03-20 | KeyBanc | Overweight | Overweight | Maintains |
| 2018-03-20 | Chardan Capital | Buy | Buy | Maintains |
| 2018-03-20 | Baird | Neutral | Neutral | Maintains |
| 2018-02-07 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2018-02-07 | Baird | Neutral | Neutral | Maintains |
| 2018-01-24 | JP Morgan | Overweight | Overweight | Maintains |
| 2017-03-31 | Cantor Fitzgerald | Overweight | Initiate | |
| 2017-03-22 | Chardan Capital | Buy | Reiterate | |
| 2017-02-07 | Chardan Capital | Buy | Initiate | |
| 2017-01-23 | KeyBanc | Overweight | Initiate | |
| 2016-12-13 | Chardan Capital | Buy | Initiate | |
| 2016-09-12 | Raymond James | Outperform | Maintains | |
| 2016-09-07 | Baird | Neutral | Maintains | |
| 2016-06-08 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2016-04-04 | Leerink Swann | Outperform | Maintains | |
| 2016-03-23 | Barrington Research | Outperform | Maintains | |
| 2016-03-23 | Avondale Partners | Market Outperform | Maintains | |
| 2016-01-25 | Leerink Swann | Outperform | Maintains | |
| 2015-08-17 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2015-07-08 | Leerink Swann | Outperform | Maintains | |
| 2015-06-09 | Baird | Neutral | Maintains | |
| 2015-03-25 | Leerink Swann | Outperform | Maintains | |
| 2015-03-25 | JP Morgan | Overweight | Maintains | |
| 2015-03-06 | Leerink Swann | Outperform | Initiate | |
| 2015-02-19 | Barrington Research | Outperform | Initiate | |
| 2014-08-25 | Wells Fargo | Outperform | Initiate | |
| 2014-08-25 | SunTrust Robinson Humphrey | Overweight | Initiate | |
| 2014-08-25 | Raymond James | Outperform | Initiate | |
| 2014-08-25 | JP Morgan | Outperform | Initiate | |
| 2023-03-22 | Barrington Research | Outperform | Reiterate | |
| 2023-03-22 | RBC Capital | Outperform | Reiterate | |
| 2023-03-24 | Deutsche Bank | Buy | Maintains | |
| 2023-06-01 | Barrington Research | Outperform | Outperform | Reiterate |
| 2023-06-06 | RBC Capital | Outperform | Reiterate | |
| 2023-06-07 | Deutsche Bank | Buy | Buy | Maintains |
| 2023-12-04 | Barrington Research | Outperform | Outperform | Reiterate |
| 2024-06-04 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-06-04 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-06-04 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-06-04 | B of A Securities | Buy | Buy | Maintains |
| 2024-06-04 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2024-06-04 | Baird | Outperform | Outperform | Maintains |
| 2023-12-13 | Raymond James | Outperform | Outperform | Maintains |
| 2023-09-06 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-12-01 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-09-06 | Barrington Research | Outperform | Outperform | Reiterate |
| 2023-09-07 | Deutsche Bank | Buy | Buy | Maintains |
| 2023-12-06 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-09-21 | Baird | Neutral | Outperform | Upgrade |
| 2024-04-04 | JMP Securities | Market Outperform | Initiate | |
| 2024-03-20 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-03-20 | B of A Securities | Buy | Buy | Maintains |
| 2024-04-02 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-03-22 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-03-22 | Keybanc | Overweight | Overweight | Maintains |
| 2024-02-23 | Barclays | Overweight | Overweight | Maintains |
| 2024-02-23 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-03-20 | BTIG | Buy | Buy | Maintains |
| 2024-06-07 | Raymond James | Outperform | Outperform | Maintains |
| 2024-06-05 | Keybanc | Overweight | Overweight | Maintains |
| 2024-07-03 | B of A Securities | Buy | Buy | Maintains |
| 2024-06-20 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-11-14 | BTIG | Buy | Buy | Maintains |
| 2024-11-15 | Goldman Sachs | Neutral | Initiate | |
| 2024-11-13 | B of A Securities | Buy | Buy | Maintains |
| 2024-09-04 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
| 2024-09-04 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-09-04 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-09-04 | B of A Securities | Buy | Buy | Maintains |
| 2025-04-11 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-03-19 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-12-04 | Mizuho | Outperform | Initiate | |
| 2024-09-20 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-03-27 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2024-08-30 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-09-04 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-04-16 | Keybanc | Overweight | Overweight | Maintains |
| 2025-02-25 | Raymond James | Outperform | Outperform | Maintains |
| 2025-03-14 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-03-24 | Keybanc | Overweight | Overweight | Maintains |
| 2024-12-10 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-12-10 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2024-12-02 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-03-25 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2025-02-26 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-06-04 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2025-06-04 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2025-06-04 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-06-04 | B of A Securities | Buy | Buy | Maintains |
| 2025-08-28 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-06-05 | Deutsche Bank | Buy | Buy | Maintains |
| 2025-06-05 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-08-29 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-07-08 | Raymond James | Strong Buy | Strong Buy | Reiterate |
| 2025-09-03 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-09-03 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-09-03 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-09-03 | Jefferies | Buy | Buy | Maintains |
